3Piccini JP, Whellan D J, Berridge BR, et al. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative [ J ]. Am Heart J, 2009,158 ( 3 ) : 317-326.
4Hanafy S, E1-Kadi AO, Jamali F. Drug-disease interaction : reduced verapamil response in isoproterenol-induced myocardial injury in rats [ J ]. Pharmacology, 2010,86 ( 4 ) : 196-202.
5Wong SM, Chiu PY, Leung HY, et al. Myocardial post- conditioning with Danshen-Gegen decoction protects againstisoproterenol-induced myocardial injury via a PKCepsilon/ mKATP-mediated pathway in rats [ J ]. Chin Med, 2011,6 (1) :7.
6Stanely MPP, Priya S. Preventive effects of rutin on lysosomal enzymes in isoproterenol induced cardio toxic rats : biochemical, histological and in vitro evidences [ J ]. Eur J Pharmacol,2010,649( 1 - 3 ) :229-235.
7Mceann CJ, Glover BM, Menown IB, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T[ J ]. Eur Heart J,2008, 29(23 ) :2843-2850.
